Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancer (Q43766558)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancer |
scientific article |
Statements
1 reference
Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancer (English)
1 reference
J P Stevenson
1 reference
M Redlinger
1 reference
L A Kluijtmans
1 reference
W Sun
1 reference
K Algazy
1 reference
B Giantonio
1 reference
D G Haller
1 reference
C Hardy
1 reference
A S Whitehead
1 reference
P J O'Dwyer
1 reference
1 October 2001
1 reference
1 reference
19
1 reference
20
1 reference
4081-4087
1 reference
Identifiers
1 reference
1 reference